Potential for activation of an abnormal alarm pause.
Source facts
Action
Mindray contacted consignees via letter on about 08/15/2025. consignees were instructed that they may continue to use the BeneVision N1 patient monitor as a multi-parameter module with Mindray host monitors. Per the additional guidance, it is recommended to confirm that the remaining alarm time counter is actively displayed and follows the existing N1 Operator's Manual: Instructions for when the Alarm Pause is Activated. An image was also included in the notification letter showing the correctly displayed Alarm Pause notification and timer.
Consignees were also requested to make all applicable clinical staff aware of the issue and to complete and return the Acknowledgement and Receipt form. Mindray's Care team will deploy a software update to correct the issue. Distributors were advised to contact their direct customers and notify them directly.
Initiated
2025-08-15
Root cause
Software design
Distribution
Worldwide - Nationwide distribution and the country of Canada.
Recall number
Z-2622-2025
Recall status
Open, Classified
CDRH record ID
215600
FDA classified
2025-09-25
Recall event number
97437
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.